A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (11) , 1839-1854
- https://doi.org/10.1016/s0149-2918(00)89080-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clozapine and Risperidone Treatment of Psychosis in Parkinson's DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2000
- Comparative Efficacy of Risperidone and Clozapine in the Treatment of Patients With Refractory Schizophrenia or Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2000
- Atypical antipsychotics and weightgain — a systematic reviewActa Psychiatrica Scandinavica, 2000
- The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophreniaInternational Journal of Psychiatry in Clinical Practice, 2000
- Clinical and Neurocognitive Effects of Clozapine and Risperidone in Treatment-Refractory Schizophrenic PatientsThe Journal of Clinical Psychiatry, 1998
- An Open Comparison of Clozapine and Risperidone in Treatment-Resistant SchizophreniaPharmacopsychiatry, 1998
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- ICI 204,636 (SEROQUEL™): A Dibenzothiazepine Atypical Antipsychotic. Review of Preclinical Pharmacology and Highlights of Phase II Clinical TrialsCNS Drug Reviews, 1995